Acoramidis hydrochloride (ALXN2060) is an orally administered, selective kinetic stabilizer of both wild-type and V122I variant transthyretin (TTR). It is a research compound used in preclinical and clinical studies investigating therapeutic strategies for TTR amyloidosis, including cardiomyopathy and polyneuropathy.